Related Experiment Video
Updated: Apr 12, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
Cardiac remodeling pathways do not accelerate disease onset and severity in a mouse model of PLN-R14del
Liu Sun1, Elisabeth M Schouten1, Karla Arevalo Gomez1
1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Insights
Cardiac pressure overload from transverse aortic constriction (TAC) did not accelerate disease in a Phospholamban (PLN)-R14del mouse model. Common cardiac stress pathways alone are insufficient to trigger PLN-R14del cardiomyopathy.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Disease Modeling
Background:
- Phospholamban (PLN)-R14del is a pathogenic variant linked to ventricular arrhythmias and dilated cardiomyopathy.
- Disease onset and severity in PLN-R14del carriers show high heterogeneity, suggesting other factors influence progression.
Purpose of the Study:
- To investigate if cardiac pressure overload, induced by transverse aortic constriction (TAC), accelerates disease onset in a heterozygous PLN-R14del mouse model (R14Δ/+) .
Main Methods:
- A heterozygous PLN-R14del mouse model (R14Δ/+) underwent TAC surgery to induce pressure overload.
- Wild-type littermates and sham-operated controls were used for comparison.
- Cardiac structure, function, gene expression, and sarco-endoplasmic reticulum integrity were assessed post-surgery.
Main Results:
- TAC induced cardiac remodeling (increased wall thickness, ventricular/atrial weights, reduced ejection fraction) in both R14Δ/+ and wild-type mice.
- Gene expression analysis revealed comparable activation of cardiac remodeling and stress pathways in both groups.
- Importantly, TAC did not induce sarco-endoplasmic reticulum malformation in R14Δ/+ mice, indicating PLN-R14del-specific pathology was not triggered.
Conclusions:
- Transverse aortic constriction provokes significant cardiac remodeling and activates common stress pathways in young adult mice, irrespective of PLN-R14del genotype.
- Pressure overload alone is insufficient to trigger PLN-R14del-specific sarco-endoplasmic reticulum malformation or accelerate disease progression in this model.
- These findings suggest that common cardiac stress pathways are not the sole drivers for accelerating PLN-R14del cardiomyopathy in early adulthood.
Abstract:
PLN-R14del is a pathogenic Phospholamban (PLN) gene variant, characterized by ventricular arrhythmias and dilated cardiomyopathy in heterozygous carriers. Disease development is highly heterogeneous, indicating involvement of additional disease triggers, influencing both the onset and severity of the disease. A heterozygous PLN-R14del mouse model (R14Δ/+) was used to investigate whether cardiac pressure induced by transverse aortic constriction (TAC), could accelerate disease onset.Wild-type littermates and sham operated animals were used as controls. surgery. At 6-weeks, both TAC groups exhibited increased in left ventricular wall thickness, ventricular and atrial weights, and reduced ejection fraction, with comparable hypertrophic and fibrotic responses. Furthermore, differential gene expression showed comparable activation of cardiac remodeling and stress pathways, and changes in metabolic genes expression. Importantly, TAC did not induce sarco-endoplasmic reticulum malformation in R14Δ/+ mice, suggesting that general cardiac stress and remodeling pathways are insufficient to trigger PLN-R14del cardiomyopathy .In conclusion, TAC induced pressure overload provoked robust cardiac remodeling with activation of common stress pathways in young adult WT and R14Δ/+ mice. It did not trigger PLN-R14del-specific sarco-endoplasmic malformation or accelerate disease progression. These findings imply that activation of common cardiac stress pathways alone may be insufficient to accelerate the onset of PLN-R14del cardiomyopathy in early adulthood.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

